Brooklyn Investment Group’s Gilead Sciences GILD Stock Holding History

Brooklyn Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.08M	Buy	29,288 +8,141	+38%	+$1.14M	0.13%	120
2025 Q4	$2.64M	Buy	21,147 +8,858	+72%	+$1.08M	0.12%	138
2025 Q3	$1.36M	Sell	12,289 -348	-3%	-$39.6K	0.18%	112
2025 Q2	$1.4M	Buy	12,637 +3,651	+41%	+$389K	0.18%	109
2025 Q1	$1.01M	Buy	8,986 +3,033	+51%	+$313K	0.22%	91
2024 Q4	$550K	Buy	5,953 +662	+13%	+$59.6K	0.16%	106
2024 Q3	$444K	Buy	+5,291	New	+$404K	0.15%	126
2024 Q1	–	Sell	-5,847	Closed	-$474K	–	235
2023 Q4	$474K	Buy	+5,847	New	+$455K	0.23%	102

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Brooklyn Investment Group's GILD Position: Q1 2026 in Review

Brooklyn Investment Group increased its Gilead Sciences (GILD) stake by 38% in Q1 2026, buying an estimated $1.14M and bringing the position to 29,288 shares worth $4.08M. The position accounts for 0.13% of the portfolio, ranked #120.

Brooklyn Investment Group first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Brooklyn Investment Group held 29,288 shares of Gilead Sciences worth $4.08M as of Q1 2026.
Brooklyn Investment Group bought 8,141 Gilead Sciences shares in Q1 2026, an estimated $1.14M.
Gilead Sciences made up 0.13% of Brooklyn Investment Group's portfolio in Q1 2026, its #120 holding.
Brooklyn Investment Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.